ClearNote Health to Present Strong ASCO 2026 Data for Avantect Pancreatic Cancer Blood Test
SAN DIEGO, May 22, 2026 ClearNote Health announced that it will present new multi-cohort validation data for its Avantect®...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SAN DIEGO, May 22, 2026 ClearNote Health announced that it will present new multi-cohort validation data for its Avantect®...
December 19, 2025 | Salt Lake City, Utah — Wasatch BioLabs announced a co-marketing agreement with Agilent Technologies to...
